Last updated Aug 4, 2026
BridgeBio Pharma, Inc. (BBIO) is a publicly traded company. This page tracks every superinvestor 13F holding, congressional stock trade, and Form 4 insider transaction in BBIO. Across our datasets, 4 superinvestors hold BBIO.
Notable holders include Viking Global, Ray Dalio, and Polen Capital.
Key takeaways
